PocDoc

• 29/11/2024
• Series A
• $6,343,125

PocDoc is a digital health platform developed with the vision of allowing anyone with a smartphone or tablet to test themselves for a range of major diseases or conditions via a fingerprick of blood, receive a full health assessment that puts those results in context and then be offered solutions to address any health-related issues that arise.

The PocDoc platform has been designed to work with our proprietary, quantitative blood tests, which have been developed in-house and are focused on preventative disease areas (Cardiovascular Disease, Metabolic Disease and Renal Disease ). The platform can also integrate other existing rapid tests, digitise the results, and provide the same health assessment and follow-on care pathways.

PocDoc successfully rolled out the PocDoc Healthy Heart Check, which focuses on cardiovascular disease in homes, communities, healthcare organisations and pharmacies across the United Kingdom. PocDoc's technology has been granted multiple patents worldwide and is set to be the first home testing diagnostic service to fully integrate with the NHS app.

Featured in the BBC News, BBC Breakfast News, The Daily Mail, The Telegraph and The Guardian.

PocDoc has won 3 Innovate UK awards and MedTech Breakthrough award for its technology.

For more information and to book a screening, visit www.pocdoc.co or follow us on Twitter / Facebook / Instagram on @mypocdoc

---

---